MedPath

浙江华润三九众益制药有限公司

Ownership
-
Established
2006-01-26
Employees
-
Market Cap
-
Website
www.zhypharm.com

Clinical Trials

0

Active:0
Completed:0

Trial Phases

0 Phases

Drug Approvals

58

NMPA:58

Drug Approvals

Desloratadine

Product Name
地氟烷
Approval Number
国药准字H20100059
Approval Date
Sep 30, 2024
NMPA

Tetrandrine Tablets

Product Name
汉防己甲素片
Approval Number
国药准字H33022163
Approval Date
Sep 20, 2024
NMPA

Potassium Magnesium Aspartate Tablets

Product Name
门冬氨酸钾镁片
Approval Number
国药准字H33021881
Approval Date
Sep 20, 2024
NMPA

Cefuroxime Sodium for Injection

Product Name
凯帝欣
Approval Number
国药准字H20041984
Approval Date
Mar 8, 2024
NMPA

Cefuroxime Sodium for Injection

Product Name
凯帝欣
Approval Number
国药准字H20020086
Approval Date
Mar 1, 2024
NMPA

Cefuroxime Sodium for Injection

Product Name
凯帝欣
Approval Number
国药准字H20020084
Approval Date
Mar 1, 2024
NMPA

Azithromycin Enteric-coated Capsules

Product Name
阿奇霉素肠溶胶囊
Approval Number
国药准字H20090152
Approval Date
Nov 2, 2023
NMPA

Magaldrate

Product Name
镁加铝
Approval Number
国药准字H20080082
Approval Date
May 29, 2023
NMPA

Azithromycin Tablets

Product Name
阿奇霉素片
Approval Number
国药准字H20084458
Approval Date
May 23, 2023
NMPA

Magaldrate Chewable Tablets

Product Name
镁加铝咀嚼片
Approval Number
国药准字H20123405
Approval Date
Aug 25, 2022
NMPA
  • Prev
  • 1
  • 2
  • 3
  • 4
  • 5
  • 6
  • Next

Clinical Trials

No trials found

News

No news found

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.